Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -16.67% | -9.09% | -35.90% |
28/05 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
28/05 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.90% | 14Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Raymond James Adjusts Price Target on Compass Therapeutics to $8 From $5, Maintains Outperform Rating